<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>BD Newsroom (Product)</title>
<link>https://news.bd.com/</link>
<description></description>
<item>
<title>BD Advances Immunology Research by Enabling Researchers to Investigate 30 Immune Markers in a Single Experiment</title>
<link>https://news.bd.com/2021-01-13-BD-Advances-Immunology-Research-by-Enabling-Researchers-to-Investigate-30-Immune-Markers-in-a-Single-Experiment</link>
<description>The BD® AbSeq Immune Discovery Panel enables researchers to execute single cell experiments with high efficiency</description>
<pubDate>Wed, 13 Jan 2021 08:00:00 -0500</pubDate>
<guid>https://news.bd.com/2021-01-13-BD-Advances-Immunology-Research-by-Enabling-Researchers-to-Investigate-30-Immune-Markers-in-a-Single-Experiment</guid>
</item>
<item>
<title>BD Announces First-Ever Peer-Reviewed Study to Evaluate Specific Outcomes from Using Midline Catheters for Blood Draws </title>
<link>https://news.bd.com/2021-01-11-BD-Announces-First-Ever-Peer-Reviewed-Study-to-Evaluate-Specific-Outcomes-from-Using-Midline-Catheters-for-Blood-Draws</link>
<description>Peer-reviewed clinical study published in the Journal of the Association for Vascular Access supports the use of midline catheters as an effective method for blood collection while reducing number of venipunctures </description>
<pubDate>Mon, 11 Jan 2021 08:00:00 -0500</pubDate>
<guid>https://news.bd.com/2021-01-11-BD-Announces-First-Ever-Peer-Reviewed-Study-to-Evaluate-Specific-Outcomes-from-Using-Midline-Catheters-for-Blood-Draws</guid>
</item>
<item>
<title>BD Announces Canadian Government Order of More Than 7 Million Portable, Rapid Point-of-Care Antigen Tests to Detect SARS-CoV-2 in 15 minutes</title>
<link>https://news.bd.com/2020-11-10-BD-Announces-Canadian-Government-Order-of-More-Than-7-Million-Portable-Rapid-Point-of-Care-Antigen-Tests-to-Detect-SARS-CoV-2-in-15-minutes</link>
<description></description>
<pubDate>Tue, 10 Nov 2020 16:01:00 -0500</pubDate>
<guid>https://news.bd.com/2020-11-10-BD-Announces-Canadian-Government-Order-of-More-Than-7-Million-Portable-Rapid-Point-of-Care-Antigen-Tests-to-Detect-SARS-CoV-2-in-15-minutes</guid>
</item>
<item>
<title>BD Receives Order from Dutch Ministry of Health for More than Nine Million 15-minute COVID-19 Antigen Tests</title>
<link>https://news.bd.com/2020-11-02-BD-Receives-Order-from-Dutch-Ministry-of-Health-for-More-than-Nine-Million-15-minute-COVID-19-Antigen-Tests</link>
<description>The first shipment of 1.2 million SARS-CoV-2 Assays for use on the BD Veritor™ Plus System to be delivered in The Netherlands by mid-November</description>
<pubDate>Mon, 02 Nov 2020 01:00:00 -0500</pubDate>
<guid>https://news.bd.com/2020-11-02-BD-Receives-Order-from-Dutch-Ministry-of-Health-for-More-than-Nine-Million-15-minute-COVID-19-Antigen-Tests</guid>
</item>
<item>
<title>CerTest Biotec and BD Announce CE Mark for Combination COVID-19, Influenza, RSV Test on BD MAX™ Molecular Diagnostic System</title>
<link>https://news.bd.com/2020-10-21-CerTest-Biotec-and-BD-Announce-CE-Mark-for-Combination-COVID-19-Influenza-RSV-Test-on-BD-MAX-TM-Molecular-Diagnostic-System</link>
<description></description>
<pubDate>Wed, 21 Oct 2020 02:00:00 -0400</pubDate>
<guid>https://news.bd.com/2020-10-21-CerTest-Biotec-and-BD-Announce-CE-Mark-for-Combination-COVID-19-Influenza-RSV-Test-on-BD-MAX-TM-Molecular-Diagnostic-System</guid>
</item>
<item>
<title>BD Announces Assay for Immune Assessment of COVID-19 Patients Now Available in Europe</title>
<link>https://news.bd.com/2020-10-16-BD-Announces-Assay-for-Immune-Assessment-of-COVID-19-Patients-Now-Available-in-Europe</link>
<description>BD Multitest™ 6-Color TBNK Reagent with BD Trucount™ Tubes brings time-tested immune assessment solution to European clinicians treating COVID-19 patients </description>
<pubDate>Fri, 16 Oct 2020 03:00:00 -0400</pubDate>
<guid>https://news.bd.com/2020-10-16-BD-Announces-Assay-for-Immune-Assessment-of-COVID-19-Patients-Now-Available-in-Europe</guid>
</item>
<item>
<title>BD Granted FDA 510(k) Clearance for BD FACSLyric™ Flow Cytometer with Newly Integrated BD FACSDuet™ Sample Preparation System</title>
<link>https://news.bd.com/2020-10-05-BD-Granted-FDA-510-k-Clearance-for-BD-FACSLyric-TM-Flow-Cytometer-with-Newly-Integrated-BD-FACSDuet-TM-Sample-Preparation-System</link>
<description>BD FACSDuet™ Sample Preparation System, now available in the U.S., as the first fully automated sample-to-answer solution when integrated with the BD FACSLyric™ Flow Cytometer</description>
<pubDate>Mon, 05 Oct 2020 06:52:00 -0400</pubDate>
<guid>https://news.bd.com/2020-10-05-BD-Granted-FDA-510-k-Clearance-for-BD-FACSLyric-TM-Flow-Cytometer-with-Newly-Integrated-BD-FACSDuet-TM-Sample-Preparation-System</guid>
</item>
<item>
<title>BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes</title>
<link>https://news.bd.com/2020-09-30-BD-Announces-CE-Mark-of-Portable-Rapid-Point-of-Care-Antigen-Test-to-Detect-SARS-CoV-2-in-15-minutes</link>
<description>SARS-CoV-2 Assay for BD Veritor™ Plus System to be available in Europe by end of October</description>
<pubDate>Wed, 30 Sep 2020 03:00:00 -0400</pubDate>
<guid>https://news.bd.com/2020-09-30-BD-Announces-CE-Mark-of-Portable-Rapid-Point-of-Care-Antigen-Test-to-Detect-SARS-CoV-2-in-15-minutes</guid>
</item>
<item>
<title>BD Submits Pre-Market Approval Supplement to FDA to Enable ThinPrep® Pap Test™ PreservCyt® Solution to be Used with the BD Onclarity™ HPV Assay</title>
<link>https://news.bd.com/2020-09-23-BD-Submits-Pre-Market-Approval-Supplement-to-FDA-to-Enable-ThinPrep-R-Pap-Test-TM-PreservCyt-R-Solution-to-be-Used-with-the-BD-Onclarity-TM-HPV-Assay</link>
<description></description>
<pubDate>Wed, 23 Sep 2020 06:59:00 -0400</pubDate>
<guid>https://news.bd.com/2020-09-23-BD-Submits-Pre-Market-Approval-Supplement-to-FDA-to-Enable-ThinPrep-R-Pap-Test-TM-PreservCyt-R-Solution-to-be-Used-with-the-BD-Onclarity-TM-HPV-Assay</guid>
</item>
<item>
<title>BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error</title>
<link>https://news.bd.com/2020-09-21-BD-Announces-FDA-Classifications-for-August-4th-Recalls-of-BD-Alaris-TM-System-Hardware-for-Keypads-Incorrect-Module-Types-and-or-Sizes-and-Channel-Error</link>
<description>Three Recalls Designated as Class I by FDA; One Designated as Class II</description>
<pubDate>Mon, 21 Sep 2020 06:59:00 -0400</pubDate>
<guid>https://news.bd.com/2020-09-21-BD-Announces-FDA-Classifications-for-August-4th-Recalls-of-BD-Alaris-TM-System-Hardware-for-Keypads-Incorrect-Module-Types-and-or-Sizes-and-Channel-Error</guid>
</item>
</channel>
</rss>
